Login

Paul Grint Discusses AmpliPhi Biosciences - Paul Grint, CEO, AmpliPhi Biosciences Corp 00:00:00

Share On Facebook Share On Twitter

Paul Grint Discusses AmpliPhi Biosciences

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Navigating international expansion and dividend policies amidst rising real estate prices| Marnix Galle, CEO, Compagnie Immobiliere de Belgique.
00:10:00
Microvision CEO Sumit Sharma asserts increased confidence in the company's pursuit of lidar market dominance.
00:00:00
Neurologist and psychiatrist / Alice Weaver Flaherty, M.D., Ph.D.
00:10:00
A Conversation with PIMCO's CEO on Economic Outlook, Investment Strategy, and Global Dynamics |  Emmanuel Roman, CEO, PIMCO.
00:10:00
Lawrence Stroll Discusses Aston Martin's F1 Reveal and Pandemic Impact on Business | Lawrence Stroll, Chairman, Lawrence Stroll Aston Martin Lagonda Global Holdings PLC.
00:10:00
High Demand and Premium Valuations in Pharma, Cold Chain, and E-Commerce Logistics
00:10:00
C4XD aims to efficiently deliver world leading immunoinflammatory medicines|Clive Dix,CEO,C4X Discovery Holdings
00:10:00
Antony Beckmand Explores Ertelien’s Historic Drilling Program in Latest Kuniko Interview | Antony Beckmand , CEO, Kuniko Limited.
00:10:00
Inca One Secures $20M Debt Facility for Expansion and Upgrades in Peru
00:10:00
Building an RIA During Crisis: Brian O'Neal's Journey
00:10:00
RS Minerals Announces Key Soil Results and New License Acquisition in Kazakhstan
00:10:00
Debevoise & Plimpton LLP Honored with The 2019 Jonathan Lippman Award

© 2017 - Neuhu+